Shoukir Y, Campana A, Farley T, Sakkas D
Clinic of Infertility and Gynaecological Endocrinology-WHO Collaborating Centre, Department of Obstetrics and Gynaecology, University Hospital of Geneva, Switzerland.
Hum Reprod. 1997 Jul;12(7):1531-6. doi: 10.1093/humrep/12.7.1531.
A number of non-invasive methods have been proposed to evaluate embryo viability in human in-vitro fertilization programmes. In addition to biochemical analyses, a common method for the selection of embryos prior to transfer involves assessment of embryo quality and morphology. We propose a new method to evaluate embryo viability based on the timing of the first cell division. Fertilized embryos that had cleaved to the 2-cell stage 25 h post-insemination were designated as 'early cleavage' embryos while the others that had not yet reached the 2-cell stage were designated as 'no early cleavage'. In all cases the early cleavage embryos were transferred when available. Early cleavage was observed in 27 (18.9%) of the 143 cycles assessed. There were significantly (chi2 = 4.0; P = 0.04) more clinical pregnancies in the early cleavage group, 9/27 (33.3%), compared with the no early cleavage group, 17/116 (14.7%). No difference was found when comparing key parameters (age, stimulation protocol and semen characteristics) of couples belonging to both groups, pointing to an intrinsic property or factor(s) within the early cleaving embryos. We propose 'early cleavage' as a simple and effective non-invasive method for selection and evaluation of embryos prior to transfer.
已经提出了许多非侵入性方法来评估人类体外受精程序中胚胎的活力。除了生化分析外,在胚胎移植前选择胚胎的常用方法包括评估胚胎质量和形态。我们提出了一种基于首次细胞分裂时间来评估胚胎活力的新方法。受精后25小时分裂至2细胞期的胚胎被指定为“早期分裂”胚胎,而其他尚未达到2细胞期的胚胎被指定为“无早期分裂”。在所有情况下,有可用的早期分裂胚胎时就进行移植。在评估的143个周期中,有27个(18.9%)观察到早期分裂。早期分裂组的临床妊娠率显著更高(χ2 = 4.0;P = 0.04),为9/27(33.3%),而无早期分裂组为17/116(14.7%)。比较两组夫妇的关键参数(年龄、刺激方案和精液特征)时未发现差异,这表明早期分裂胚胎内部存在一种内在特性或因素。我们提出“早期分裂”作为一种简单有效的非侵入性方法,用于在胚胎移植前进行选择和评估。